ANRO Investors Have Opportunity to Lead Alto Neuroscience, Inc. Securities Fraud Lawsuit
1. Rosen Law Firm has filed a class action lawsuit for ANRO stock purchasers. 2. The lawsuit alleges false statements about ALTO-100's effectiveness and business prospects. 3. Class action claims potential damages for investors from misleading communications. 4. Lead plaintiffs must file motions by September 19, 2025, to represent the class. 5. No class is certified; investors can choose counsel or stay absent.